|
|
Management and Core Advisors Team
Michael Packard- Mr. Packard is the President and CEO of HPO and also is a member of the Board of Directors of HPO. In late 1999, Mr. Packard created his own firm, TransCat Consulting, helping organizations “make change that matters.” In addition to his consulting roles, Mr. Packard has filled the interim CEO or general manager roles of several clients. From 1989-1999, Mr. Packard’s role as Executive VP and Chief Administrative Officer at LensCrafters was key to creating the most successful optical retailer in the world and one of the most successful U.S. retailers. In addition to his roles at LensCrafters (1987-1999) and Procter & Gamble (1971-1987), Mr. Packard was the key outside Director on the Board of Innotech, Inc., a high-tech optical company from 1992-1997. He has a Chemical Engineering Degree from Bucknell University (1970) and an MBA from Virginia (1972). Continuing education includes the Change Leadership Program from Wharton and the Retail Executive Program from Harvard.
Andrew W. Ishak O.D. -
Dr. Ishak is the Vice
President, Chief
Visionary Officer, and
member of the Board of
Directors of HPO.
Dr. Ishak conceived of
the business market
opportunity/need of HPO.
His background as
President and CEO of
Bayz Polarized Sunwear
lead to the development
of the science behind
HPO for its proprietary
blue blocking colorless
filtration technology.
Dr. Ishak is also
Vice-President of Vision
Associates, one of the
largest private
professional Optometric
practices in the
Mid-Atlantic region of
the U.S. His
ability to network with
key individuals in the
Vision Care Industry and
coordinate their
activities from R&D to
prototyping, to IP as
bolstered the potential
for HPO success.
He holds five patents
with multiple pending
patent applications.
He is a published author
and graduated from
Pennsylvania College of
Optometry in 1987.
Sean P. Mcginnis, Ph.D. - Dr. McGinnis is an Entrepreneurial Scientific Advisor and Chief Technology Officer for HPO. He is a researcher skilled in optical thin films and processing with expertise in understanding sustainable manufacturing processes. From 1998 -2005, Dr. McGinnis was an R&D research scientist, project lead, and group leader in the areas of scratch resistant, anti-reflective, tintable, hydrophobic, and other functional coatings and manufacturing processes for ophthalmic lenses for Johnson & Johnson’s Spectacle Lens Group. Dr. McGinnis is a Senior Research Scientist at Virginia Polytechnic Institute and State University. He received his Ph.D. in Materials Science and Engineering from Stanford University.
Leslie K. Gardner - Ms. Gardner serves as Marketing Consultant for HPO. Ms. Gardner brings well over a decade of optical industry marketing experience from SOLA International, Inc., and SOLA Optical USA and over 25 years of business expertise from a variety of diverse industries to her current role in Aligned Growth Partners. While at SOLA, Ms. Gardner held positions of Group Vice-President for strategic marketing, Group Vice-President for new business development, and Vice-President of marketing worldwide. She has been an active member of SOLA International and SOLA Optical USA, Executive Committees accountable for new business and corporate strategic initiatives. During her tenure at SOLA, Ms. Gardner was instrumental in more than tripling sales revenue, with double digit growth that outpaced industry growth every year. Ms. Gardner graduated summa cum laude with a BS degree from SUNY Buffalo and earned an MBA with distinction from the Stern School of Business at NYU.
Mark Mattison-Shupnick - Mr. Mattison-Shupnick is New Product Consultant for HPO. His areas of expertise are market research, product development, project management and ophthalmic optics training for the industry. His clients include major lens manufacturers, regional and national chains, lens processing laboratories, as well as optometric management consulting and buying groups. Mr. Mattison-Shupnick coordinates the continuing education program for 20/20 Magazine, Jobson Publishing, LLC, the largest trade publisher in the ophthalmic industry. Mr. Mattison-Shupnick has earned the rare title of Master Optician and is a globally recognized consultant, speaker, and trainer.
HPO Advisors
Ronald Blum, O.D. - Dr. Blum is founder, Chairman of The Egg Factory, LLC, Chairman, President and CEO of PixelOptics, Inc. He has had great success in building diverse management teams needed to develop products as well executing business strategies. He is a visionary, innovator, and businessman. Dr. Blum is named as the inventor on over 150 patents and patent applications. He has been on the editorial advisory Boards of two National Vision Care Industry publications. Dr. Blum has also has substantial commercial innovation success, including Innotech which, was sold in 1997 to Johnson & Johnson for $135 million. Innotech was founded by Dr. Blum in 1990, and under his direction as Chairman and CEO was taken public on the NASDAQ exchange in 1996 before being sold in 1997. Dr. Blum remained with Johnson & Johnson until March 1999 serving as General Manager of Advanced Technologies for the Spectacle Lens Group of Johnson & Johnson, where he lead and managed the team that invented and developed the “Definity” Progressive Addition Lens. The “Definity” was acquired by Essilor, the largest lens manufacturer in the world. Prior to founding Innotech, Inc., Dr. Blum founded in 1977, Drs Blum, Newman, Blackstock & Associates, Optometrists, P.C. Dr. Blum recently served on the Board of Trustees for Roanoke College. Dr. Blum received his Doctorate of Optometry degree from the Southern College of Optometry.
William Burns - Mr. Burns serves as: Advisor of Marketing and Advertising for HPO. He is currently President/CEO of Encore, Inc, an early startup in the pharmaceutical arena. From Jan. 2000- June 2005 Mr. Burns served as Vice President of Global Marketing, Consumer and Pharmaceutical Products for Alcon where he directed the brand launch of Systane Lubricant Eye Drops worldwide and directed the team market plan launch of Optifree, the Contact Lens Care Solution line. During this time Mr. Burns represented $600 million of the $4 billion dollars sales of Alcon products. From Jan. 1996- Dec. 1999 Mr. Burns served as Vice President of International Marketing, Pharmaceutical and Consumer Products for Alcon where he directed the preparation of Alcon’s first global launch for the anti-glaucoma drug Travatan, which have current sales of $200 million. Mr. Burns has a Bachelor of Arts from Slippery Rock University with a Major in Biology and Minor in Chemistry. He attended the Program for Management Development from the Harvard Business School and the Framework for Strategic Thinking and Planning from Columbia University.
Dan Durrie, M.D. – Dr. Durrie the leader of the Durrie Vision refractive surgery team. With more than 20 years of experience, he is an internationally known pioneer in procedures to correct nearsightedness, farsightedness, and astigmatism. He is based in Kansa City, and is Clinical Professor Ophthalmology at the University of Kansas Medical Center. Dr. Durrie has been recognized as one of the top 10 refractive surgeons in the nation. His scientific articles and papers have appeared in numerous medical professional publications and he is on the editorial board of Ocular Surgery News, The Journal of Ophthalmology and Refractive Surgery, and the Review of Ophthalmology and Refractive Eyecare for Ophthalmologists. Dr. Durrie has given hundreds of presentations for professional organizations world-wide.
Amitava Gupta, Ph.D. - Dr. Gupta is a widely recognized authority in the areas of devices for vision correction, including spectacle lenses, implants and contact lenses, optical materials, clinical research, fabrication processes including precision machining and molding, laser spectroscopy, laser interaction with materials, and materials and coatings for use in spacecrafts. His career has included significant positions at the Jet Propulsion Laboratory, Ioptex Research (IOL development), and the Spectacle Lens Group (J&J). At J&J, Dr.Gupta was responsible for all research and development activities of the company from product development through moving into manufacturing processes. In 2005 Dr. Gupta joined Vistakon (J&J) as a Senior Principal Research Fellow, responsible for technical guidance to develop a product for presbyopic correction, and overall responsibility to assess and strengthen the technical infrastructure of the organization. Dr. Gupta received his doctorate from the California Institute of Technology. Over the years he has received a number of awards and has served on a wide range of both professional and industrial advisory boards.
Peter D. Haaland, Ph.D. - Dr. Haaland is Technology Consultant for HPO. He is a business-focused researcher highly skilled in creating profitable ventures by melding interdisciplinary sciences. Dr. Haaland has developed, patented, and licensed an anti-reflective ophthalmic lens coating process for Johnson & Johnson. Dr. Haaland developed and patented a spin-coating process for semiconductor thin films cutting costly material waste. Invented and patented new materials to aid daytime detection of ultraviolet light. Dr. Haaland was also: Chief Scientist at NanoBlox, Managing Partner of ZigYag Lt., General Partner of Phyrx Ltd., CEO of Mobium Enterprises Inc., Founder of Flexor Ltd., and Associate Professor of Physics for the U.S. Air Force Institute of Technology (1988-1992). Dr. Haaland graduated from Harvard University with a Ph.D., M.A., and B.A. in chemistry. He holds eight issued patents and five pending patents. He has published over 40 papers in peer-reviewed journals.
John Hunkeler, M.D. – Dr. Hunkeler is founder and medical director of Hunkeler Eye Institute. Specializing in cataract and lens implant surgery, Dr. Hunkeler has maintained a private practice in the metropolitan Kansas City area since 1973. Dr. Hunkeler has helped educate ophthalmologists throughout the world in the technique of small incision cataract surgery. He was the first surgeon to use the YAG laser in Kansas City in 1984 and the excimer laser in 1988. In October 1996, he was recognized by Ophthalmology Times as one of the top 100 ophthalmologists in the United States. In 1977, Dr. Hunkeler was the founding director of the Kansas City Eye Bank and served as its medical director for the next 10 years. He also served as a medical monitor for the laser photorefractive keratectomy study for nearsightedness. Additionally, Dr. Hunkeler has facilitated the use of Hunkeler Eye Institute as the national training facility for physicians interested in learning about excimer laser procedures in refractive surgery procedures. As chairman of the Department of Ophthalmology at the University of Kansas School of Medicine, Dr. Hunkeler oversees the training of ophthalmology residents at the school. Dr. Hunkeler earned his medical degree from the University of Kansas and continued his medical training with an internship at the Los Angeles County Hospital and subsequent ophthalmic residency at the University of Kansas. Also, he has held leadership roles in many ophthalmic organizations and served on the boards of the Outpatient Ophthalmic Surgery Society, the American Board of Eye Surgery, and the Eye Bank Association of America. Dr. Hunkeler is a board-certified ophthalmologist and past president of the American Society for Cataract and Refractive Surgery.
Richard Lindstrom, M.D. - Dr. Lindstrom is founder and managing partner of Minnesota Eye Consultants, is a board-certified ophthalmologist and internationally recognized leader in corneal, refractive and laser surgery. He has been at the forefront of ophthalmology's evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon. Dr. Lindstrom graduated Magna Cum Laude from the College of Liberal Arts at the University of Minnesota, and continued on to complete his doctorate degree in medicine in 1972. In 1980, Dr. Lindstrom returned to the University of Minnesota, where he spent ten years on the faculty of the Department of Ophthalmology, the last two as the Harold G. Scheie Research Chair. He entered private practice in 1990, and has led the growth and expansion of Minnesota Eye Consultants as managing partner. Dr. Lindstrom conceptualized the Phillips Eye Institute Center for Teaching and Research in Minneapolis, a state-of-the-art ophthalmic research and surgical skills education facility, and serves as its medical director. He continues to play an active role in teaching and training at the Phillips Eye Institute and the University of Minnesota. Dr. Lindstrom also serves as medical director and board member of Laser Vision Centers, Inc., and Midwest Surgical Services, as well as associate director of the Minnesota Lions Eye Bank. Dr. Lindstrom holds 28 patents in ophthalmology, including intraocular lens implant technology, corneal preservation, irrigation solutions, viscoelastic solutions, intracorneal lenses and associated surgical instruments. He has designed a number of intraocular lenses and instruments that are used in clinical practices globally. A frequent lecturer throughout the world on cornea, cataract and refractive surgery, he has presented 28 named lectures and keynote speeches before professional societies in the U.S. and abroad.
Gerald M. Ostrov – Mr. Ostrov is currently Chairman and Chief Executive Officer for Bausch & Lomb. Mr. Ostrov retired January 1, 2006 as Company Group Chairman responsible for Johnson & Johnson’s Worldwide Vision Care businesses. Mr. Ostrov was a member of the Worldwide Consumer and Personal Care Group Operating Committee. Mr. Ostrov began his career with Johnson & Johnson’s Health Care Division in 1976. In 1982, he left Johnson & Johnson to become Vice President of Marketing for Ciba-Geigy’s Consumer Pharmaceuticals Company. He was named President of Ciba Consumer Pharmaceuticals in 1985 and served in that capacity until rejoining Johnson & Johnson in 1991 as President of the corporation’s Personal Products Company. In 1993, he was promoted to Company Group Chairman and added Northern Europe C&PC products to his responsibilities. In 1995, he became responsible for all Consumer and Personal Care businesses in North America. He assumed Vision Care global current responsibilities on October 1, 1998. Mr. Ostrov is Chairman of the Board of Trustees of Middlesex County College (NJ). He is a Member of the Board of Trustees of the Garden State Arts Foundation (NJ). He was a member of the Cornell University Council. He is a former Board member of the Non-Prescription Drug Manufacturers Association, and served as Vice President of Finance and an Executive Committee member. Mr. Ostrov also served on the Johnson & Johnson Corporate Contributions Committee. Mr. Ostrov serves on the Board of the Jewish Federation of Greater Middlesex, Oscar and Ella Wilf Campus for Jewish Life, and the East Brunswick (NJ) Jewish Center, and served as President of the latter from 1991-92. He is also past and founding President of the East Brunswick (NJ) Education Foundation. A native of Brooklyn, New York, Mr. Ostrov was born on October 29, 1949. Mr. Ostrov earned a Bachelor of Science degree with distinction in Industrial Engineering and Operations Research from Cornell University and holds an M.B.A. from Harvard University.
James Schumer, M.D. - Dr. Schumer is a practicing ophthalmologist in Columbus Ohio. His particular area of interest has been in clinical ophthalmology -- specializing in cornea, external disease, and refractive surgery. Throughout the years, he has been involved in ophthalmic research to help advance patient care and assist industry in bringing devices to market. Dr. Schumer graduated from the Medical College of Ohio, followed by an internship at the Oakwood Hospital and residency at the Henry Ford Hospital (both in Detroit, Michigan). He then served a fellowship at the Hunkeler Eye Clinic in Kansas City, Missouri. Since then, Dr. Schumer has continued to be active in research and publishing in the area of retinal surgery and devices, as well as his ophthalmology practice.
Leo Semes, O.D., Associate Professor of Optometry. - Dr. Semes received his doctorate from the Pennsylvania College of Optometry. Following graduation he served a one-year fellowship in Primary Care at the Eye Institute of PCO. Dr. Semes then joined the faculty at UAB. Currently, he is associate professor and director of continuing education. He has received AOSA’s excellence in teaching award on three occasions as well UAB President’s award for teaching excellence. Dr. Semes is the author of over 25 referenced scientific papers and posters and has published over 60 articles. In addition, he has contributed to the optometric literature through a co-authored book as well as numerous book chapters. Most recently, he has been named to 2000 Outstanding Intellectuals of the21st Century.
Janet Sparrow, Ph.D. - Dr. Sparrow is a Scientific Advisor for HPO (though receiving no compensation of any kind). She is a Professor of Ophthalmic Science and currently Director of the Retinal Cell Biology Laboratory at the Edward S. Harkness Eye Institute at Columbia University. She is internationally recognized, respected, and published for her work in identifying specific retinal photochemical byproducts and their correlation with HEVL damage and AMD. Dr. Sparrow was instrumental in determining the functionality characteristics for the “Restor” intra-ocular lens recently released from Alcon. She has received the following awards: Research to Prevent Blindness, Lew R. Wasserman Merit Award, and the Alcon Research Institute Award.
|
|
